Biotechnology Jobs

• Waltham, United States
• US$202,125 – US$336,875 pa
• Director

Drives the development and execution of the analytical/QC testing network strategy across GSK's global supply chain, translating approved strategy into operational roadmaps and securing governance endorsement. Partners with Quality, MSAT, R&D and product leads on NPI and commercial supply, benchmarks industry best practice, and builds KPI reporting and risk mitigation for large molecules, ADCs and Oligos.

• London
• US$202,125 – US$336,875 pa
• Director

Drives the development and execution of the analytical network strategy across GSK's supply chain, defining QC testing network principles and translating them into an operational roadmap. Partners with GSC Quality, MSAT, R&D and governance forums on NPI and commercial supply decisions, with a focus on large molecules, ADCs and oligonucleotides. Benchmarks industry practice and builds KPI reporting and capability within the GSC Strategy team.

• London
• Hybrid
• Director · manages people

Leads GSK's Forward Deployed Engineering function for CMC R&D, setting strategy, hiring and mentoring engineers, and owning senior BU sponsor relationships. Personally contributes to strategic engagements building digital twins, physical AI and self-driving lab capability, using AI coding agents as the primary development mode.

Claude Code · GitHub Copilot · Databricks AI Assistant +3

• USA - Pennsylvania - Upper Providence
• Hybrid
• Director

Individual-contributor alliance lead owning an established central laboratory partnership, balancing strategic direction with hands-on governance. Runs governance forums, monitors KPIs and study delivery, resolves urgent operational issues, and embeds a new operating model, using AI tools to analyse large datasets.

Claude

• USA - Pennsylvania - Upper Providence
• Hybrid · 2 days in office
• US$242,250 – US$403,750 pa
• Director · manages people

Owns the clinical strategy, scientific narrative and benefit-risk framework for genitourinary cancer assets, acting as the senior clinical authority on the Medicine Development Team core quad. Sets asset-level evidence-generation and governance direction while Senior Scientists handle study-level delivery, and represents Clinical Development in health authority and external engagements. Hybrid role with at least two on-site days per week.

AI · Advanced Analytics

• Durham
• Hybrid · 2–3 days in office
• €87,000 – €145,000 pa
• Director

Provides medical and scientific expertise in safety evaluation and risk management for GSK assets across clinical development and post-marketing settings. Leads signal detection, regulatory periodic reports, and benefit-risk assessments while collaborating with cross-functional teams including Clinical Operations, Regulatory, and Biostatistics. Involves presenting complex safety issues to senior governance committees and contributing to global regulatory submissions.

ICH · GVP · CIOMS

• Greater Poland
• Hybrid · 2–3 days in office
• €87,000 – €145,000 pa
• Director
• Permanent

Provides medical and scientific expertise in safety evaluation and risk management for GSK assets across clinical development and post-marketing settings. Leads signal detection, benefit-risk assessment, regulatory periodic reports and RMPs, working within a global cross-functional matrix alongside Clinical Operations, Regulatory and Biostatistics. Distinct for its strong focus on pharmacovigilance governance, safety strategy and scientific writing.

ICH · GVP · CIOMS

• London
• Hybrid · 2–3 days in office
• €87,000 – €145,000 pa
• Director
• Permanent

Provides medical and scientific expertise in safety evaluation and risk management for GSK assets across clinical development and post-marketing settings. Leads signal detection, periodic regulatory reports, RMPs and benefit-risk assessments within a global cross-functional matrix, presenting complex safety issues to senior governance committees. Distinct for its blend of pharmacovigilance strategy, regulatory writing and matrix leadership.

ICH · GVP · CIOMS

• Belgium-Wavre
• Hybrid · 2–3 days in office
• €87,000 – €145,000 pa
• Director
• Permanent

Provides medical and scientific expertise in safety evaluation and risk management for GSK assets across clinical development and post-marketing settings. Leads signal detection, benefit-risk assessment, regulatory periodic reports and RMPs, and contributes to safety strategy within a global cross-functional matrix. Involves presenting complex safety issues to senior governance committees and mentoring matrix colleagues.

ICH · GVP · CIOMS

• USA - Pennsylvania - Upper Providence
• US$188,100 – US$313,500 pa
• Director

Leads quantitative systems pharmacology and QST modelling within a clinical pharmacology and quantitative medicine group, building mechanistic mathematical models of disease and drug action to inform trial design and MIDD strategy. Collaborates with biologists, clinicians, pharmacometricians and AI/ML teams, and represents the function on internal advisory boards.

• London
• Hybrid
• US$188,100 – US$313,500 pa
• Director
• Permanent

Leads quantitative systems pharmacology and QST modelling within a clinical pharmacology and quantitative medicine group, building mechanistic models of disease and drug action and running simulations to inform trial design. Defines and coordinates MIDD strategies across respiratory, immunology and inflammation programmes, working with biologists, clinicians, pharmacometricians and AI/ML specialists. The role sits in a newly formed centre of excellence and involves representing QSP on internal advisory boards.

• Durham Blackwell Street
• US$188,100 – US$313,500 pa
• Director

Leads quantitative systems pharmacology and QST modelling within a clinical pharmacology and quantitative medicine group, building mechanistic models of disease and drug action and running simulations to assess trial design. Defines and coordinates MIDD strategies across respiratory, immunology and inflammation programmes, working with biologists, clinicians, pharmacometricians and AI/ML specialists. The role sits in a newly established Centre of Excellence for model-informed drug development.

• Warsaw, Poland
• On-site
• US$284,250 – US$473,750 pa
• Director

Leads clinical development of GU oncology assets, designing and executing Phase 1-3 trials and serving as a core member of the Clinical Matrix Team. Provides real-time medical monitoring, safety review with pharmacovigilance, and authors clinical study reports and regulatory responses. Builds external expert relationships and contributes to business development diligence.

Real World Evidence (RWE)

• London
• Hybrid · 2 days in office
• US$222,750 – US$371,250 pa
• Director

Provides clinical and scientific leadership across cardiovascular clinical development programmes, shaping study designs, translational plans and regulatory documents within the Respiratory, Immunology & Inflammation Research Unit. Leads a Clinical Matrix Team, oversees participant safety and medical monitoring, and works cross-functionally with biology, regulatory, statistics and commercial partners. Hybrid working with at least two days per week on-site.

• Waltham, United States
• Hybrid · 2 days in office
• US$222,750 – US$371,250 pa
• Director

Leads clinical development strategy for cardiovascular assets within the Respiratory, Immunology & Inflammation Research Unit, designing clinical development plans, protocols and regulatory documents while providing medical monitoring and safety oversight. Chairs the Clinical Matrix Team and serves as primary clinical contact for regulators, investigators and key external experts across early and late-stage programs.